MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 03-09-2026
Anixa Biosciences Depreciation & Amortization 2011-2026 | ANIX
Annual Depreciation & Amortization Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 38.3 K | 47.6 K | 18.4 K | 43.2 K | 33.3 K | 12.5 K | 314 K | - | 7.23 K | 7.98 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 314 K | 7.23 K | 58.1 K |
Quarterly Depreciation & Amortization Anixa Biosciences
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15 K | 38.3 K | 29.4 K | - | 6.13 K | 33 K | 18.1 K | 126 K | 4.39 K | 12.4 K | 7.37 K | 81.3 K | 10.5 K | 32.1 K | 21.3 K | 81.3 K | 3.85 K | 24.9 K | 13.9 K | 81.3 K | 1.02 K | 244 K | 81.3 K | 81.3 K | 70.5 K | 233 K | 81.3 K | 81.4 K | 1.42 K | - | - | - | 2.08 K | - | - | - | 1.93 K | 5.99 K | 3.98 K | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 244 K | 1.02 K | 47.8 K |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
321 M | $ 115.93 | 0.34 % | $ 35.2 B |  USA |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
1.11 M | $ 1.67 | - | $ 2.22 M | USA |
 |
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 25.24 | 3.19 % | $ 701 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
15 M | $ 21.47 | 1.13 % | $ 1.14 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Illumina
ILMN
|
354 M | $ 127.5 | -0.3 % | $ 20.3 B | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 16.0 | -1.9 % | $ 484 M | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
Charles River Laboratories International
CRL
|
403 M | $ 173.04 | 1.93 % | $ 8.58 B | USA |
 |
Lantheus Holdings
LNTH
|
70.1 M | $ 84.45 | 0.14 % | $ 5.7 B | USA |
 |
Guardant Health
GH
|
39.7 M | $ 89.29 | 0.43 % | $ 11.2 B | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 415.78 | 1.28 % | $ 12 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
425 K | $ 1.91 | -3.29 % | $ 8.45 M | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
1.51 M | $ 7.08 | 0.35 % | $ 295 M | USA |
 |
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
2.02 M | $ 52.73 | 0.01 % | $ 2.68 B | USA |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.51 | -0.37 % | $ 2.06 B | USA |
 |
Biomerica
BMRA
|
87 K | $ 2.16 | 0.93 % | $ 4.96 M | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 17.21 | -0.12 % | $ 385 M | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 100.91 | -1.24 % | $ 8.32 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
681 M | $ 263.12 | -0.24 % | $ 21.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.05 B | $ 467.91 | -0.35 % | $ 176 B | USA |
 |
Celcuity
CELC
|
167 K | $ 122.2 | 0.96 % | $ 5.71 B | USA |
 |
OpGen
OPGN
|
175 K | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
36.1 M | $ 8.54 | 3.02 % | $ 1.09 B | USA |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 60.33 | -1.0 % | $ 3.61 B | USA |
 |
Myriad Genetics
MYGN
|
53.7 M | $ 4.8 | 0.31 % | $ 444 M | USA |
 |
Natera
NTRA
|
16.7 M | $ 204.58 | 0.41 % | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 196.1 | -0.06 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
405 M | - | -0.91 % | $ 14.7 B | USA |